BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Prognosis
12 results:

  • 1. Characterisation of the cell and molecular biological effect of peptide-based daunorubicin conjugates developed for targeting pancreatic adenocarcinoma (PANC-1) cell line.
    Szász Z; Enyedi KN; Takács A; Fekete N; Mező G; Kőhidai L; Lajkó E
    Biomed Pharmacother; 2024 Apr; 173():116293. PubMed ID: 38430628
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. An integrated analysis identifies six molecular subtypes of pancreatic ductal adenocarcinoma revealing cellular and molecular landscape.
    Li L; Shen L; Wu H; Li M; Chen L; Zhou Q; Ma J; Huai C; Zhou W; Wei M; Zhao M; Zhao X; Du H; Jiang B; Sun Y; Zhang N; Qin S; Xing T
    Carcinogenesis; 2023 Dec; 44(10-11):726-740. PubMed ID: 37747815
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The role of intraperitoneal chemotherapy in the surgical management of pancreatic ductal adenocarcinoma: a systematic review.
    Brind'Amour A; Webb M; Parapini M; Sidéris L; Segedi M; Chung SW; Chartier-Plante S; Dubé P; Scudamore CH; Kim PTW
    Clin Exp Metastasis; 2021 Apr; 38(2):187-196. PubMed ID: 33486670
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Dendritic Polyglycerol-Derived Nano-Architectures as Delivery Platforms of Gemcitabine for pancreatic cancer.
    Ray P; Ferraro M; Haag R; Quadir M
    Macromol Biosci; 2019 Jul; 19(7):e1900073. PubMed ID: 31183964
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Integrin β1 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110β signaling.
    Yang D; Tang Y; Fu H; Xu J; Hu Z; Zhang Y; Cai Q
    Biochem Biophys Res Commun; 2018 Oct; 505(1):215-221. PubMed ID: 30243721
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms.
    Berardi R; Torniai M; Partelli S; Rubini C; Pagliaretta S; Savini A; Polenta V; Santoni M; Giampieri R; Onorati S; Barucca F; Murrone A; Bianchi F; Falconi M
    PLoS One; 2018; 13(5):e0197035. PubMed ID: 29787601
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Driver Mutational Landscape of Ovarian Squamous Cell Carcinomas Arising in Mature Cystic Teratoma.
    Cooke SL; Ennis D; Evers L; Dowson S; Chan MY; Paul J; Hirschowitz L; Glasspool RM; Singh N; Bell S; Day E; Kochman A; Wilkinson N; Beer P; Martin S; Millan D; Biankin AV; McNeish IA;
    Clin Cancer Res; 2017 Dec; 23(24):7633-7640. PubMed ID: 28954785
    [No Abstract]    [Full Text] [Related]  

  • 8. Integrinβ1 modulates tumour resistance to gemcitabine and serves as an independent prognostic factor in pancreatic adenocarcinomas.
    Yang D; Shi J; Fu H; Wei Z; Xu J; Hu Z; Zhang Y; Yan R; Cai Q
    Tumour Biol; 2016 Sep; 37(9):12315-12327. PubMed ID: 27289231
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis.
    Liu L; Zhi Q; Shen M; Gong FR; Zhou BP; Lian L; Shen B; Chen K; Duan W; Wu MY; Tao M; Li W
    Oncotarget; 2016 Jul; 7(30):47145-47162. PubMed ID: 27323403
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Significance of phospho-vascular endothelial growth factor receptor-2 expression in pancreatic cancer.
    Doi Y; Yashiro M; Yamada N; Amano R; Ohira G; Komoto M; Noda S; Kashiwagi S; Kato Y; Fuyuhiro Y; Hirakawa K
    Cancer Sci; 2010 Jun; 101(6):1529-35. PubMed ID: 20367641
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers.
    Koopmann J; Buckhaults P; Brown DA; Zahurak ML; Sato N; Fukushima N; Sokoll LJ; Chan DW; Yeo CJ; Hruban RH; Breit SN; Kinzler KW; Vogelstein B; Goggins M
    Clin Cancer Res; 2004 Apr; 10(7):2386-92. PubMed ID: 15073115
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.